SMAD2 and infection: As shown in Figures 6A–C, compared with CT-treated mice, the expression levels of smad2, smad3, and smad4 mRNA were substantially higher in immunized mice at 6 and 12 h post-pneumococcal strain 19F infection and were also significantly higher than those in P17-treated SPY1-vaccinated mice.